InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.13
(
0.97%
)
US TECH 100
19,549.60
(
1.38%
)
Dow Jones
42,080.37
(
0.30%
)
Brent Oil
77.74
(
0.51%
)
Bitcoin
62,442.86
(
0.50%
)
Post# of 43389
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

cowtown jay

Send PM Follow Ignore
Followers 89
Posts 6862
Boards Moderated 1
Alias Born 09/18/2009

cowtown jay

Re: None

Saturday, 07/22/2023 8:15:32 AM

Saturday, July 22, 2023 8:15:32 AM

Post# of 43389
Gilead's Magrolimab strikes out as blood cancer treatment.

I think we will once again see the ultra value lenz has to enhance the efficacy of the primary treatment therapeutic, in this case, azacitidine, which is being used in our trial as well.

https://www.reuters.com/business/healthcare-pharmaceuticals/gilead-stops-late-stage-trial-blood-cancer-treatment-2023-07-21/#:~:text=July%2021%20(Reuters)%20%2D%20Gilead,it%20would%20not%20be%20effective.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up